Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

478 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Among authors: radhakrishnan j. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Thrombotic microangiopathies.
Halevy D, Radhakrishnan J, Markowitz G, Appel G. Halevy D, et al. Among authors: radhakrishnan j. Crit Care Clin. 2002 Apr;18(2):309-20, vi. doi: 10.1016/s0749-0704(01)00004-5. Crit Care Clin. 2002. PMID: 12053836 Review.
Fludarabine treatment of cryoglobulinemic glomerulonephritis.
Rosenstock JL, Stern L, Sherman WH, Appel GB, Radhakrishnan J. Rosenstock JL, et al. Among authors: radhakrishnan j. Am J Kidney Dis. 2002 Sep;40(3):644-8. doi: 10.1053/ajkd.2002.34928. Am J Kidney Dis. 2002. PMID: 12200818
Use of mycophenolate mofetil in autoimmune and renal diseases.
Appel GB, Radhakrishnan J, Ginzler EM. Appel GB, et al. Among authors: radhakrishnan j. Transplantation. 2005 Oct 15;80(2 Suppl):S265-71. doi: 10.1097/01.tp.0000186389.19911.9c. Transplantation. 2005. PMID: 16251859 Review.
A 56-year-old woman with sarcoidosis and acute renal failure.
Dahl K, Canetta PA, D'Agati VD, Radhakrishnan J. Dahl K, et al. Among authors: radhakrishnan j. Kidney Int. 2008 Sep;74(6):817-21. doi: 10.1038/ki.2008.134. Epub 2008 Apr 23. Kidney Int. 2008. PMID: 18432187 Free article. No abstract available.
Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.
Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, Li LS, Mysler E, Sánchez-Guerrero J, Solomons N, Wofsy D; Aspreva Lupus Management Study Group. Appel GB, et al. J Am Soc Nephrol. 2009 May;20(5):1103-12. doi: 10.1681/ASN.2008101028. Epub 2009 Apr 15. J Am Soc Nephrol. 2009. PMID: 19369404 Free PMC article. Clinical Trial.
478 results